The tumor-suppressive effects of methyl 3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate were investigated and demonstrated that dual inhibition of MDH1 and MDH2 is an effective approach to target tumor metabolism (Naik et al., 2017). The gene discussed is MDH1; the disease is neoplasm.